Titan Medical Inc (TMDIF)

[Endofanera]

Intuitive has a very close eye on Titan and other players in this market. Getting a device to market slower than a competitor means a loss of market share and therefore revenue. Intuitive wants its device to the market first and ensure it meets all the needs of the customers.

While they will get to the market first, Titan has the advantage over Intuitive in that it meets the the growing needs of many hospitals (price, mobility, snake-arm design, etc) and can eat into Intuitive market share.

As ddreturns mentioned, cannibalizing the market share from those large companies is minor due to their diversification. Obviously many large companies are itching to get into this space and take some market share from Intuitive. Unless they are developing robots on the back end, this will likely come through M&A - much better ROI than developing your own robotic divisions along with all the R&D and clinical trial costs. Titan has the technology and is a ripe contender for this.

A lot of M&A activity is being shifted to later-stage companies (FDA) and inclusive of CE market. Small amount is occurring for developmental stage companies. I don't think Titan will go it alone; a large medical device company will pick up Titan right around or after CE mark. It will be a company that's hungry to beat out Intuitive from their market share.

Check out this SVB market report if you haven't already http://bit.ly/1ydUvMG